Transaction details
Sanifarma
Ethica Group with Fidia Farmaceutici in the purchase of a business unit from Sanifarma
Ethica Group, with the M&A Advisory team, assisted Fidia Farmaceutici, a world leader in the research, development, production and marketing of innovative products based on hyaluronic acid and its derivatives, in completing the purchase of a business unit of Sanifarma, a reference company in Italy in the marketing of contact lenses, eye drops and solutions, glasses and supplements.
Sanifarma, based in Rome, operates in the marketing of contact lenses, solutions, eye drops, glasses and food supplements, mainly distributed in pharmacies and parapharmacies. In 2023, in Italy the company recorded a market share of approximately 70% for contact lens sales (with 8 million units sold) and 35% for lens solutions.